RxDoctor Payments Data

Steven Schnittman

Infectious Disease · West Haven, CTNPI 1669560124

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $362,033 of the $362,745 with a category attached, or 99.8%. 5 manufacturers reported payments, led by Biohaven Pharmaceuticals, Inc. at 39.3% of the total. Reporting peaked in 2021 at $204,879 and has fallen 98.8% since, to $2,475 in 2023. Among infectious disease clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$362,745in general payments, 2019–2025

Across 124 payments — averaging $2925.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceuticals, Inc.$143K
  • E.r. Squibb & Sons, L.L.C.$112K
  • Biohaven Pharmaceutical Holding Company Ltd.$90K
  • Optinose US, Inc.$14K
  • Vertex$5K

What the payments were for

  • Consulting fees$362,033100%
  • Travel & lodging$4390%
  • Food & beverage$2720%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$362,745 in reported general payments places this provider in the 95th percentile of 159 infectious disease providers in Connecticut.

See all infectious disease providers in Connecticut

Other infectious disease in West Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →